Back to Results
First PageMeta Content
Pharmaceutical industry / Food and Drug Administration / Clinical research / Duragesic / Fentanyl / Transdermal patch / Adverse event / Varenicline / Botulinum toxin / Medicine / Pharmaceutical sciences / Pharmacology


FDA Patient Safety News: Show #74, April 2008
Add to Reading List

Open Document

File Size: 135,04 KB

Share Result on Facebook

Company

Actavis / Pfizer / Abrika Pharmaceuticals / Fentanyl (Duragesic) Patches / ALZA Corporation / CryoLife Inc. / /

Country

United States / /

Event

FDA Phase / Product Issues / Product Recall / /

Facility

The Institute / /

IndustryTerm

injection site / healthcare / botulinum toxin product / tight glucose control protocols / manufacturing process / drug information systems / healthcare professionals / heavy machinery / insulin products / /

MedicalCondition

Caution Giving Children Cough / botulism / common cold / chronic pain / blood clots / fatigue / obesity / old psychiatric illness / hypoglycemia / cerebral palsy / convulsions / respiratory failure / fainting / dyspnea / dysphagia and respiratory insufficiency / dysphagia / psychiatric illness / dysphonia / dangerous hyperglycemia / endocarditis / venous thromboembolism / respiratory depression / dizziness / cough / respiratory distress / /

MedicalTreatment

birth control / Botox / sunbathing / /

Organization

Institute for Safe Medication Practices / FDA / /

Person

Cough / Cold Medicines / /

/

Position

physician / /

Product

Safe Medication / Duragesic / Chantix / regular insulin / Patches / Ortho Evra / Myobloc / ISMP Medication / Fentanyl / Humulin R / Botox Cosmetic / CII Patches / Sandoz fentanyl patches / patch / /

Technology

tight glucose control protocols / /

URL

http /

SocialTag